Ovation's real-world viral testing data provides the answers researchers need to understand a pathogen's potential impact on human health.
New insights around respiratory infectious disease rely on robust real-world data
Efforts to understand SARS-CoV-2 and the implications for transmission and clinical manifestations have taught us the importance of analyzing viral genome sequence data in combination with patient clinical and genomic data. Knowledge about infectious disease severity and susceptibility is reliant on data that provides a complete picture.
Our diverse network of diagnostic labs are frequently testing for respiratory pathogens and contributing consented, de-identified samples and data to Ovation’s database.
Explore a sample cohort
Ovation’s database addresses research questions such as:
- Are there strains/mutations associated with changes in disease severity?
- Are there strains/mutations that affect viral loads or clearance?
- Are there strains/mutations that predispose to diseases such as MIS-C?
Data can be refreshed hourly for near real time surveillance updates of patient testing and positive counts, geographic dispersal and trends over time.
Ovation’s diverse network of labs are continually surveilling for prevalent respiratory pathogens and resistance genes
Let’s work together to advance our understanding of respiratory pathogens
Our team combines the best of the tech and biotech worlds with vast experience managing large clinical, viral and genomic data sets. Our delivery teams and clinical affairs specialists work together to deliver the highest quality data.